Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Buprenorphine/ Methadone exposure
Locations
1
United States
UPMC Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States
Start Date
August 28, 2023
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
March 19, 2026
NCT06965530
NCT04587791
NCT06284278
NCT05492825
NCT06273683
NCT06651177
Lead Sponsor
Ilana Hull
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions